Exact Sciences Corp (EXAS) – Strategy, SWOT and Corporate Finance Report

Exact Sciences Corp (EXAS) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The company’s flagship product, Cologuard test is a US FDA-approved non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It uses a multi-target approach to detect DNA and hemoglobin biomarkers is related to colorectal cancer. The company also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect test, a liquid-based test designed for advanced stage prostate cancer. It operates manufacturing and laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Scope

• Detailed information on Exact Sciences Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Exact Sciences Corp in the form of a SWOT analysis

• An in-depth view of the business model of Exact Sciences Corp including a breakdown and examination of key business segments

• News about Exact Sciences Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Exact Sciences Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Exact Sciences Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Exact Sciences Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Lineage Cell Therapeutics Inc

Grail LLC

EDP Biotech Corporation

StageZero Life Sciences Ltd

Natera Inc

Freenome Inc

CellMax, Inc.

Epigenomics AG

Nucleix Ltd

Cambridge Epigenetix Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Exact Sciences Corp - Key Facts

Exact Sciences Corp - Key Employees

Exact Sciences Corp - Key Employee Biographies

Exact Sciences Corp - Major Products and Services

Exact Sciences Corp - History

Exact Sciences Corp - Company Statement

Exact Sciences Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Exact Sciences Corp - Business Description

Product Category: COVID-19 Testing

Performance

Product Category: Precision Oncology

Overview

Performance

Product Category: Screening

Overview

Performance

Geographical Segment: Outside of United States

Performance

Geographical Segment: United States

Performance

R&D Overview

Exact Sciences Corp - Corporate Strategy

Exact Sciences Corp - SWOT Analysis

SWOT Analysis - Overview

Exact Sciences Corp - Strengths

Exact Sciences Corp - Weaknesses

Exact Sciences Corp - Opportunities

Exact Sciences Corp - Threats

Exact Sciences Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Exact Sciences Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Exact Sciences Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023

Exact Sciences Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 10, 2023: Exact Sciences schedules first quarter 2023 earnings call

Feb 23, 2023: Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

Feb 21, 2023: Exact Sciences Announces Fourth Quarter 2022 Results

Jan 12, 2023: Exact Sciences Announces Second Quarter 2022 Results

Jan 08, 2023: Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Dec 09, 2022: Exact Sciences presents first time data detailing ability to predict radiation therapy benefit in breast cancer patients

Sep 22, 2022: Exact Sciences awards grants to federally qualified health centers focused on improving colorectal cancer screening of vulnerable populations

Sep 10, 2022: Exact Sciences demonstrates power of multi-cancer early detection approach with data presentation at the 2022 European Society for Medical Oncology Congress

Aug 02, 2022: Exact Sciences Announces Second Quarter 2022 Results

Jun 21, 2022: Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costs

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Exact Sciences Corp, Key Facts

Exact Sciences Corp, Key Employees

Exact Sciences Corp, Key Employee Biographies

Exact Sciences Corp, Major Products and Services

Exact Sciences Corp, History

Exact Sciences Corp, Subsidiaries

Exact Sciences Corp, Key Competitors

Exact Sciences Corp, Ratios based on current share price

Exact Sciences Corp, Annual Ratios

Exact Sciences Corp, Annual Ratios (Cont…1)

Exact Sciences Corp, Annual Ratios (Cont…2)

Exact Sciences Corp, Interim Ratios

Exact Sciences Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Exact Sciences Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023

Exact Sciences Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Exact Sciences Corp, Performance Chart (2018 – 2022)

Exact Sciences Corp, Ratio Charts

Exact Sciences Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023

Exact Sciences Corp, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports